Browsing by Author "Carvalho, Andrea Teixeira de"
Now showing items 34-53 of 59
-
Leishmania infantum induces high phagocytic capacity and intracellular nitric oxide production by human proinflammatory monocyte
Ribeiro, Christiana Vargas et al. | Date Issued: 2020 -
Living in endemic area for infectious diseases accelerates epigenetic age
Durso, D.F. et al. | Date Issued: 2022 -
Modulation of Regulatory T Cells Activity by Distinct CD80 and CD86 Interactions With CD28/CTLA-4 in Chagas Cardiomyopathy
Pinto, Bruna F. et al. | Date Issued: 2022 -
Multifunctional T cell response in convalescent patients two years after ZIKV infection
Pereira Neto, Tertuliano Alves et al. | Date Issued: 2020 -
Multiple inflammatory markers and 15-year incident ADL disability in admixed older adults: The Bambui-Epigen Study
Costa, Maria Fernanda Lima et al. | Date Issued: 2017 -
Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients
Wowk, Pryscilla Fanini et al. | Date Issued: 2017 -
New features on the survival of human-infective Trypanosoma rangeli in a murine model: Parasite accumulation is observed in lymphoid organs
Ferreira, Luciana de Lima et al. | Date Issued: 2020 -
Pamidronate, a promising repositioning drug to treat leishmaniasis, displays antileishmanial and immunomodulatory potential
Ribeiro, Juliana Martins et al. | Date Issued: 2022 -
Panoramic snapshot of serum soluble mediator interplay in pregnant women with convalescent COVID-19: an exploratory study
Fernandes, Geraldo Magela et al. | Date Issued: 2023 -
Papel dos Receptores do tipo Toll na malária
Franklin, Bernardo Simões | Date Issued: 2009Desde sua descoberta, os receptores do tipo Toll (TLRs) têm sido envolvidos em quase todas as doenças que afetam a saúde humana. Seu papel na proteção contra vários patógenos, incluindo protozoários está bem estabelecido. ... -
pcDNA-IL-12 vaccination blocks eosinophilic inflammation but not airway hyperresponsiveness following murine Toxocara canis infection
Malheiro, Adriana et al. | Date Issued: 2008 -
Performance of TcI/TcVI/TcII Chagas-Flow ATE-IgG2a for universal and genotype-specific serodiagnosis of Trypanosoma cruzi infection
Alessio, Glaucia Diniz et al. | Date Issued: 2017 -
Plasma biomarkers profile of female dogs with mammary carcinoma and its association with clinical and pathological features
Lima, Alessandra Estrela da Silva et al. | Date Issued: 2016 -
Plasmodium vivax Infection Impairs Regulatory T-Cell Suppressive Function During Acute Malaria
Costa, Pedro Augusto Carvalho et al. | Date Issued: 2018 -
Produção de uma proteína recombinante do ovo de Schistosoma mansoni e avaliação de desempenho pelo imunoensaio de ELISA indireta empregando amostras sorológicas humana
Moraes, Vanessa Silva | Date Issued: 2018A esquistossomose ainda é considerada um problema de saúde pública mundial. O avanço integrado das ações de controle nos últimos anos resultou na diminuição da morbidade e consequentemente no aumento de áreas de baixa ... -
Produtos Naturais e Substâncias Sintéticas como Fontes Inovadoras para o Tratamento de Doenças Negligenciadas.
Fagundes, Elaine Maria de Souza et al. | Date Issued: 2013 -
Profile of Central and Effector Memory T Cells in the Progression of Chronic Human Chagas Disease
Fiuza, Jacqueline Araujo et al. | Date Issued: 2009 -
Protective profile involving CD23/IgE-mediated NO release is a hallmark of cutaneous leishmaniasis patients from the Xakriabá indigenous community in Minas Gerais, Brazil.
Gontijo, Raquel Carvalho et al. | Date Issued: 2015 -
Selecting targets for the diagnosis of Schistosoma mansoni infection: An integrative approach using multi-omic and immunoinformatics data.
Carvalho, Gardenia Braz Figueiredo de et al. | Date Issued: 2017 -
O sistema imune inato na patogênese da malária
Hirako, Isabella Cristina | Date Issued: 2016Por muitas décadas de estudo sobre a patogênese da malária, tem-se estabelecido que as manifestações clínicas são frequentemente uma consequência da inflamação sistêmica provocada pelo parasito. Os imunocomplexos (ICs) ...